- Home
- RGCO vs CMPX Comparison
RGCO vs CMPX Comparison
Compare RGCO & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGCO
- CMPX
- Stock Information
- Founded
- RGCO 1912
- CMPX 2014
- Country
- RGCO United States
- CMPX United States
- Employees
- RGCO N/A
- CMPX N/A
- Industry
- RGCO Oil & Gas Production
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- RGCO Utilities
- CMPX Health Care
- Exchange
- RGCO Nasdaq
- CMPX Nasdaq
- Market Cap
- RGCO 201.4M
- CMPX 214.6M
- IPO Year
- RGCO N/A
- CMPX N/A
- Fundamental
- Price
- RGCO $21.47
- CMPX $2.61
- Analyst Decision
- RGCO
- CMPX Strong Buy
- Analyst Count
- RGCO 0
- CMPX 4
- Target Price
- RGCO N/A
- CMPX $13.75
- AVG Volume (30 Days)
- RGCO 16.4K
- CMPX 2.2M
- Earning Date
- RGCO 02-03-2025
- CMPX 11-12-2024
- Dividend Yield
- RGCO 3.79%
- CMPX N/A
- EPS Growth
- RGCO 1.73
- CMPX N/A
- EPS
- RGCO 1.16
- CMPX N/A
- Revenue
- RGCO $84,641,232.00
- CMPX $850,000.00
- Revenue This Year
- RGCO $7.25
- CMPX N/A
- Revenue Next Year
- RGCO $5.62
- CMPX $613.39
- P/E Ratio
- RGCO $18.01
- CMPX N/A
- Revenue Growth
- RGCO N/A
- CMPX N/A
- 52 Week Low
- RGCO $17.90
- CMPX $0.77
- 52 Week High
- RGCO $24.20
- CMPX $2.73
- Technical
- Relative Strength Index (RSI)
- RGCO 62.17
- CMPX 77.12
- Support Level
- RGCO $19.70
- CMPX $2.34
- Resistance Level
- RGCO $20.43
- CMPX $2.70
- Average True Range (ATR)
- RGCO 0.60
- CMPX 0.29
- MACD
- RGCO 0.19
- CMPX 0.12
- Stochastic Oscillator
- RGCO 90.26
- CMPX 90.98
About RGCO RGC Resources Inc.
RGC Resources Inc is involved in the business of distribution and sale of natural gas to residential, commercial, and industrial customers within its service territory in Roanoke, Virginia, and its surrounding localities. The company also provides certain non-regulated services. The company relies on multiple interstate pipelines to transport natural gas. The company operates in three segments: Gas Utility, which is the key revenue generator; Investment in Affiliates this segment reflects the income generated through the activities of the Company's investment in MVP and Southgate projects and Parent & Other including the unregulated activities of the Company as well as certain corporate eliminations.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.